Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Exenatide for Perioperative Hyperglycemia
NCT00882050Phase 2Completed
- Sponsor
- Thomas Jefferson University
- Start
- Mar 2009
- Primary completion
- Apr 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of exenatide in hyperglycemia (3 arms), sponsored by Thomas Jefferson University. Primary endpoint: Ability of Intravenous Exenatide to Maintain Intraoperative Euglycemia in Subjects With Initial Blood Glucose < 126 mg/dL. Started Mar 2009; status: completed.
02
Drugs
exenatide
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT00882050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882050.